SEC Comment Letter for BIOLARGO, INC. (BLGO) (CIK 0000880242) (BLGO) — Dec 9, 2015
BIOLARGO, INC. (BLGO) (CIK 0000880242)
Date: Dec. 9, 2015 · CIK: 0000880242 · Accession: 0000000000-15-057060
AI Filing Summary & Sentiment
Show Raw Text
December 9 , 2015 Mail Stop 4631 Via Facsimile Mr. Charles K. Dargan II Chief Financial Officer BioLargo, Inc. 3500 W. Garry Avenue Santa Ana, CA 92704 RE: BioLargo, Inc. Form 10 -K for the Year ended December 31, 2014 Filed March 31, 2015 File No. 0 -19709 Dear Mr. Dargan: We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ John Cash John Cash Accounting Branch Chief Office of Manufacturing and Construction